# New York Presbyterian Hospital Weill Cornell Medical College – FDA Inspection, Sep 28, 2016

Source: https://www.keypedia.com/records/fda_inspections/new-york-presbyterian-hospital-weill-cornell-medical-college/ce8f8886-fe1a-481d-95c9-de4d3030811a
Source feed: FDA_Inspections

> FDA inspection 988710 of New York Presbyterian Hospital Weill Cornell Medical College, September 28, 2016. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 988710
- Company Name: New York Presbyterian Hospital Weill Cornell Medical College
- Inspection Date: 2016-09-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1309054 - 2026-03-18
- FDA Inspection 1211289 - 2023-07-25
- FDA Inspection 1109017 - 2019-09-25
- FDA Inspection 878683 - 2014-05-14
- [FDA Inspection 794517 - 2012-08-20](https://www.keypedia.com/records/fda_inspections/new-york-presbyterian-hospital-weill-cornell-medical-college/7342235d-4177-4d6e-afe7-118b1c53f64e)

Company: https://www.keypedia.com/companies/new-york-presbyterian-hospital-weill-cornell-medical-college/e300af46-8628-46ca-99c5-996a3f7f6e3b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d